CID 4005

Malformin a

Structural Information

Molecular Formula
C23H39N5O5S2
SMILES
CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)N1)CC(C)C)C(C)C)NC2=O
InChI
InChI=1S/C23H39N5O5S2/c1-7-13(6)18-23(33)26-15-9-34-35-10-16(25-20(15)30)21(31)27-17(12(4)5)22(32)24-14(8-11(2)3)19(29)28-18/h11-18H,7-10H2,1-6H3,(H,24,32)(H,25,30)(H,26,33)(H,27,31)(H,28,29)
InChIKey
RNCGDQLZIATDOU-UHFFFAOYSA-N
Compound name
4-butan-2-yl-7-(2-methylpropyl)-10-propan-2-yl-15,16-dithia-2,5,8,11,19-pentazabicyclo[11.4.2]nonadecane-3,6,9,12,18-pentone
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

18
References

118
Patents

529.23926 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 530.24654 186.0
[M+Na]+ 552.22848 186.7
[M+NH4]+ 547.27308 185.7
[M+K]+ 568.20242 185.5
[M-H]- 528.23198 183.9
[M+Na-2H]- 550.21393 183.6
[M]+ 529.23871 185.3
[M]- 529.23981 185.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe